STOCK TITAN

Stoke Therapeutics: Wellington reports 7.26% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Stoke Therapeutics, Inc. (STOK) is the issuer in an amended ownership report by Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP. Each reported beneficial ownership of 4,681,855 common shares; the ownership section gives 7.26% of the class.

For the first three reporting persons, the schedule lists shared voting power over 4,417,811 shares and shared dispositive power over 4,681,855 shares. Wellington Management Company LLP lists shared voting power over 4,417,106 shares and shared dispositive power over 4,562,112 shares. Clients of Wellington investment advisers own the securities of record and have rights to dividends or sale proceeds.

Beneficially owned shares 4,681,855 shares Amount reported by each of the four Wellington reporting persons
Percent of class 7.26% Ownership section percentage
Shared voting power 4,417,811 shares Reported by Wellington Management Group LLP, Wellington Group Holdings LLP, and Wellington Investment Advisors Holdings LLP
Shared voting power 4,417,106 shares Reported by Wellington Management Company LLP
Shared dispositive power 4,681,855 shares Reported by Wellington Management Group LLP, Wellington Group Holdings LLP, and Wellington Investment Advisors Holdings LLP
Shared dispositive power 4,562,112 shares Reported by Wellington Management Company LLP
beneficially owned regulatory
"Aggregate amount beneficially owned by each reporting person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Power regulatory
"Shared voting power reported on the cover pages"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared dispositive power reported on the cover pages"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many STOK shares did the Wellington reporting persons beneficially own?

Each of the four Wellington reporting persons reported beneficial ownership of 4,681,855 Stoke Therapeutics common shares. The ownership section states this represented 7.26% of the class.

Who owns the STOK shares of record in Wellington’s ownership report?

The shares are owned of record by clients of one or more Wellington investment advisers. Those clients have the right to receive, or direct receipt of, dividends or sale proceeds; no client was identified as having that right or power with respect to more than 5% of the class.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





86150R107

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Wellington Management Group LLP
Signature:Matthew Revell
Name/Title:Compliance Manager
Date:11/16/2026
Wellington Group Holdings LLP
Signature:Matthew Revell
Name/Title:Compliance Manager
Date:11/16/2026
Wellington Investment Advisors Holdings LLP
Signature:Matthew Revell
Name/Title:Compliance Manager
Date:11/16/2026
Wellington Management Company LLP
Signature:Matthew Revell
Name/Title:Compliance Manager
Date:11/16/2026

Keep reading